SCHEMBL11067259

SCHEMBL11067259

CCC(CC)(Oc1ccc(Cc2ccc(Cl)cc2)cc1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 1/20 0.59
PPARA Q07869 13/20 0.53
CYP1A2 P05177 2/20 0.53
CYP3A4 P08684 2/20 0.53
MEN1 O00255 1/20 0.53
CYP2D6 P10635 1/20 0.53
MAPT P10636 1/20 0.53
CYP2C19 P33261 1/20 0.53
KMT2A Q03164 1/20 0.53
PPARG P37231 6/20 0.50
PPARD Q03181 3/20 0.48
FABP2 P12104 2/20 0.48
ALDH1A1 P00352 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
SLC22A12 Q96S37 1/20 0.47
ABCB11 O95342 1/20 0.47
TSHR P16473 1/20 0.47
HTR2A P28223 1/20 0.47
PMP22 Q01453 1/20 0.47
KDM4E B2RXH2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11073216 0.84 OPRK1 (0.73) OPRK1PPARACYP1A2CYP3A4MEN1
SCHEMBL7406331 0.83 PPARA (0.54) OPRK1PPARACYP1A2CYP3A4MEN1
SCHEMBL3811479 0.81 PPARA (0.81) OPRK1PPARACYP1A2CYP3A4MEN1
SCHEMBL7406841 0.81 PPARA (0.51) OPRK1PPARACYP1A2CYP3A4MEN1
SCHEMBL11750863 0.79 PPARA (0.50) OPRK1PPARACYP1A2CYP3A4MEN1
SCHEMBL10969502 0.79 PPARA (0.65) OPRK1PPARACYP1A2CYP3A4MEN1
SCHEMBL11478612 0.78 OPRK1 (0.73) OPRK1PPARACYP1A2CYP3A4MEN1
SCHEMBL23754112 0.77 PPARG (0.45) PPARACYP1A2CYP3A4MEN1CYP2D6
SCHEMBL11540230 0.76 ALDH1A1 (0.44) PPARAMAPTKMT2APPARGALDH1A1
SCHEMBL27571634 0.76 GAA (0.44) PPARACYP1A2CYP3A4MEN1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4483999-A Phenoxy alkanoic acid derivatives having the ability to lower the level of fatty substances in the blood SIEGFRIED AKTIENGESELLSCHAFT (CH) 1984-11-20 US disclosed